艾迪注射液对消化道肿瘤患者肿瘤标志物的影响  

The effects of AD injection on tumor marker in alimentary tract malignant tumors

作　　者：邓艾平[1] 唐求[1] 付廷雄[1] 王奕[1] 

机构地区：[1]武汉市中心医院,湖北武汉430014

出　　处：《中国肿瘤临床与康复》2011年第2期123-124,128,共3页Chinese Journal of Clinical Oncology and Rehabilitation

摘　　要：目的探讨艾迪注射液对消化道肿瘤康复期患者肿瘤标志物CEA、CA199及生活质量的影响。方法比较消化道肿瘤康复期患者使用艾迪注射液前后CEA、CA199检测值及生活质量评分(EORTC QLQ-C30)的变化。结果疗程前CEA为(4.23±0.57)ng/L,CA199(22.65±5.43)ng/ml;疗程后CEA(3.05±1.73)ng/L,CA199(15.69±7.25)ng/ml,两组差异无显著性(P>0.05)。疗程前QOL为50±1.77;疗程后QOL为60±1.77,两者差异有显著性(P<0.05)。结论艾迪注射液可降低结肠癌康复期患者CEA及CA199水平,但无显著差异;艾迪注射液能提高QOL得分,改善生存质量,差异有显著性。Objective To study the effects of AD injection on tumor markers（CEA,CA199） in patients with alimentary tract malignant tumors.Methods The contents of CEA and CA199 in alimentary tract carcinoma and the quality of life score of the patients were determined.The changes of CEA and CA199 before and after therapy with AD injection were observed.Results Before treatment,CEA was（4.23±0.57）ng/L,CA199 was（22.65±5.43）ng/ml;after treatment,CEA was（3.05±1.73）ng/L,CA199 was（15.69±7.25）ng/ml,there no significant differences between before and after treatment（P〉0.05）.There was significant difference in QOL score between before treatment（50±1.77） and after treatment（60±1.77,P〈0.05）.Conclusion The treatment with of AD injection can decrease the level of CEA and CA199 in alimentary tract carcinoma,but the change after treatment is not significant while its treatment can increase the QOL score,with significant difference.

关 键 词：消化道肿瘤 肿瘤标志物 生存质量 艾迪注射液 

分 类 号：R735[医药卫生—肿瘤] R730.43[医药卫生—临床医学]